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The objective of this study was to assess the validity of prevalent and incident self-reported diabetes com-
pared with multiple reference definitions and to assess the reliability (repeatability) of a self-reported diagnosis of
diabetes. Data from 10,321 participants in the Atherosclerosis Risk in Communities (ARIC) Study who attended
visit 4 (1996–1998) were analyzed. Prevalent self-reported diabetes was compared with reference definitions
defined by fasting glucose and medication use obtained at visit 4. Incident self-reported diabetes was assessed
during annual follow-up telephone calls and was compared with reference definitions defined by fasting glucose,
hemoglobin A1c, and medication use obtained during an in-person visit attended by a subsample of participants
(n = 1,738) in 2004–2005. The sensitivity of prevalent self-reported diabetes ranged from 58.5% to 70.8%, and
specificity ranged from 95.6% to 96.8%, depending on the reference definition. Similarly, the sensitivity of inci-
dent self-reported diabetes ranged from 55.9% to 80.4%, and specificity ranged from 84.5% to 90.6%. Percent
positive agreement of self-reported diabetes during 9 years of repeat assessments ranged from 92.7% to
95.4%. Both prevalent self-reported diabetes and incident self-reported diabetes were 84%–97% specific and
55%–80% sensitive as compared with reference definitions using glucose and medication criteria. Self-reported
diabetes was >92% reliable over time.
diabetes; validation study
Abbreviations: ARIC, Atherosclerosis Risk in Communities; HbA1c, hemoglobin A1c; MRI, magnetic resonance imaging.
Diabetes is often defined exclusively by using a self-
reported diagnosis in cross-sectional and prospective epide-
miologic studies (1–3). Previous studies have found that
self-reported diabetes is highly specific when medical chart
reviews or physician surveys are used to confirm cases (4–
7). However, the degree of underascertainment of diabetes
cases by self-report is less well described, and previous
studies have not quantified the performance of self-reported
diabetes by using different reference definitions.
In the United States, diabetes is estimated to affect ap-
proximately 26 million people; about one third of these
cases are undiagnosed (8). The degree of underascertain-
ment of diabetes based on self-reported information
depends on the reference (“gold”) standard used for com-
parison. Typical reference definitions incorporate fasting
glucose, hemoglobin A1c (HbA1c), and/or use of diabetes
medications. With the recent recommendations by the
American Diabetes Association for the use of HbA1c for
the diagnosis of diabetes (9), assessing the concordance of
self-reported diabetes with HbA1c is important. Our objec-
tive was to assess the validity of both prevalent and inci-
dent self-reported diabetes by using different reference
definitions and to assess the reliability (repeatability) of
self-reported diabetes in a community-based population.
MATERIALS AND METHODS
Study population
The Atherosclerosis Risk in Communities (ARIC) Study
is a community-based prospective cohort of 15,792 persons
from4US communities, which included in-person visits (10).
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All visits included an interview, physical examination, and
blood collection. Participants were asked to bring current
medication bottles to the visits, and medications were re-
corded. Visit 4 (1996–1998) was attended by 11,656 partic-
ipants and is the baseline for this analysis. Information on
fasting glucose, glucose-lowering medication use, and self-
reported diabetes was collected at visit 4. For validation of
prevalent self-reported diabetes cases, we restricted the
population to visit 4 participants who were not missing data
on self-reported diabetes, fasting glucose, or medication
use, leaving a sample size of 10,321 participants (including
1,041 with self-reported diabetes at visit 4). Beginning after
this visit, new cases of diabetes have been (and continue to
be) identified during annual telephone phone calls to all
participants.
Between 2004 and 2005, a subsample of ARIC Study
participants (n = 2,066) took part in the carotid magnetic
resonance imaging (MRI) visit (11). Information on fasting
glucose, HbA1c, and glucose-lowering medication use was
collected at the carotid MRI visit. For validation of incident
self-reported diabetes cases, we excluded participants who
did not attend both visit 4 and the carotid MRI visit, partic-
ipants with self-reported diabetes at visit 4, and those who
were missing data on fasting glucose, HbA1c, or medica-
tion use at the carotid MRI visit, leaving a sample size of
1,480 participants (including 258 with self-reported diabe-
tes during annual follow-up telephone calls occurring
between visit 4 and the carotid MRI visit).
Definition of self-reported diabetes
We classified persons as having self-reported diabetes if
they answered “yes” to any one of the following questions:
“Has a doctor ever said you have diabetes (sugar in the
blood)?” (asked at visit 4 and during annual telephone
calls); “Were any of the medications you took during the
past 2 weeks for diabetes or high blood sugar?” (asked at
visit 4); “Did you take any medications during the past 2
weeks for diabetes or high blood sugar?” (asked during
annual telephone calls).
Reference definitions for diabetes
For validation of prevalent self-reported diabetes, we
compared self-report with 2 reference definitions using in-
formation from visit 4: fasting glucose ≥126 mg/dL or dia-
betes medication use (definition 1) and fasting glucose
≥140 mg/dL or diabetes medication use (definition 2). For
validation of incident self-reported diabetes between visit 4
and the carotid MRI visit, we compared self-report with 5
reference definitions using information from the carotid
MRI visit: fasting glucose ≥126 mg/dL or diabetes medica-
tion use (definition A), fasting glucose ≥140 mg/dL or dia-
betes medication use (definition B), HbA1c ≥6.5% or
diabetes medication use (definition C), HbA1c ≥7.0% or
diabetes medication use (definition D), and fasting glucose
≥126 mg/dL or HbA1c ≥6.5% or diabetes medication use
(definition E). Cutpoints for fasting glucose were based on
current (126 mg/dL) and past (140 mg/dL) American Dia-
betes Association recommendations (9, 12). Cutpoints for
HbA1c were based on current American Diabetes Associa-
tion (6.5%) and current Department of Veterans Affairs rec-
ommendations (7.0%) (9, 13).
Reliability of self-reported diabetes
We assessed the reliability of the question: “Has a doctor
ever said you have diabetes (sugar in the blood)?” during 9
years of annual follow-up telephone calls. We performed
Table 1. Participant Characteristics at Visit 4 (1996–1998) and the
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102.3 (19.5) 103.2 (17.1)
Abbreviations: MRI, magnetic resonance imaging; SD, standard
deviation.
a Body mass index: weight (kg)/height (m)2.
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this analysis in 2 groups: 1) individuals who said “yes” to
this question at visit 4 and who participated in all annual
follow-up telephone calls after visit 4 and prior to the
carotid MRI visit and who participated in the carotid MRI
visit (n = 302 cases) and 2) individuals who said “yes” to
this question at visit 4 and who participated in at least 1
annual follow-up telephone call after visit 4 and prior to
the carotid MRI visit (n = 1,325 cases). We restricted the
populations to persons who said “yes” at visit 4 because a
diagnosis of diabetes is considered permanent.
Statistical analysis
We calculated the sensitivity (probability that persons
will self-report diabetes, given that they fulfill the reference
definition), specificity (probability that persons will not
self-report diabetes, given that they do not fulfill the refer-
ence definition), positive predictive value (probability that
persons will fulfill the reference definition, given that they
self-report diabetes), and negative predictive value (proba-
bility that persons will not fulfill the reference definition,
given that they do not self-report diabetes) for self-reported
diabetes compared with each reference definition of diabe-
tes. To assess the reliability of self-reported diabetes, we
calculated the percent positive agreement (pairwise agree-
ment between visit 4 and each follow-up telephone call)
using information collected at the annual telephone calls
that occurred between visit 4 and the carotid MRI visit. We
used logistic regression to investigate possible predictors of
high reliability, including the following variables measured
at visit 4: age, field center/race, sex, education, family
income, insurance, usual medical care, alcohol consump-
tion, cigarette smoking, prevalent heart disease, family
history of diabetes, hypertension, hypercholesterolemia,
fasting glucose, and cognitive function. High reliability was
defined as reporting a physician diagnosis of diabetes or
diabetes medication use at visit 4 and during all annual
telephone calls during follow-up.
All P values are 2 sided, and P < 0.05 was considered
statistically significant. Analyses were performed by using
Stata, version 11, statistical software (StataCorp LP, College
Station, Texas).
RESULTS
Characteristics of the 10,321 participants at visit 4 and at
the carotid MRI visit are shown in Table 1. At baseline
(visit 4), the mean age was 63 years, 57% were female, and
20% were black. The prevalence of self-reported diabetes
was 10% (n = 1,041).
The sensitivity, specificity, positive predictive value, and
negative predictive value of self-reported prevalent and in-
cident diabetes using the various reference definitions are
shown in Table 2. The sensitivity of prevalent self-reported
diabetes using definition 1 (fasting glucose ≥126 mg/dL or
medication use) was lower than when using definition 2
Table 2. Validation of Prevalenta Self-reported Diabetes at Visit 4 (1996–1998) and Incidentb Self-reported Diabetes Status (Between 1996–









95% CI PPV, % 95% CI NPV, % 95% CI
Prevalent diabetes
Definition 1: fasting glucose
≥126 mg/dL or medication use
1,287 58.5 55.8, 61.2 96.8 96.4, 97.2 72.3 69.5, 75.0 94.2 93.8, 94.7
Definition 2: fasting glucose
≥140 mg/dL or medication use
889 70.8 67.6, 73.7 95.6 95.2, 96.0 60.4 57.4, 63.4 97.2 96.8, 97.5
Incident diabetes
Definition A: fasting glucose
≥126 mg/dL or medication use
194 61.9 54.6, 68.7 89.3 87.4, 90.9 46.5 40.3, 52.8 93.9 92.5, 95.2
Definition B: fasting glucose
≥40 mg/dL or mediation use
97 80.4 71.1, 87.8 87.0 85.1, 88.7 30.2 24.7, 36.2 98.4 97.6, 99.1
Definition C: HbA1c
≥6.5% or medication use
143 59.4 50.9, 67.6 87.1 85.1, 88.8 32.9 27.2, 39.0 95.3 93.9, 96.4
Definition D: HbA1c
≥7.0% or medication use
59 64.4 50.9, 76.4 84.5 82.5, 86.4 14.7 10.6, 19.7 98.3 97.4, 98.9
Definition E: fasting glucose
≥126 mg/dL or HbA1c
≥6.5% or medication use
256 55.9 49.5, 62.0 90.6 88.8, 92.2 55.4 49.1, 61.6 90.8 89.0, 92.3
Abbreviations: CI, confidence interval; HbA1c, hemoglobin A1c; NPV, negative predictive value; PPV, positive predictive value.
a Prevalent self-reported diabetes status (total n = 10,321, self-reported n = 1,041) was defined as “yes” if the participant answered “yes” to
either “has a doctor ever said you have diabetes (sugar in the blood)?” or “were any of the medications you took during the past week for
diabetes or high blood sugar?” at visit 4 (1996–1998).
b Incident self-reported diabetes status (total n = 1,480, self-reported diabetes n = 258) was defined as “yes” if the participant answered “yes”
for the first time to either “has a doctor ever said you have diabetes (sugar in the blood)?” or “were any of the medications you took during the
past week for diabetes or high blood sugar?” during annual follow-up telephone calls after the visit 4 date and prior to the carotid magnetic
resonance imaging visit date (between 1996–1998 and 2004–2005).
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(fasting glucose ≥140 mg/dL or medication use) (59% vs.
71%). The specificities were high (>95%) when both defi-
nitions were used.
There was a similar pattern for incident self-reported dia-
betes when definition A (fasting glucose ≥126 mg/dL or
medication use) was used compared with definition B
(fasting glucose ≥140 mg/dL or medication use). The sen-
sitivity for incident self-reported diabetes was lower with
definition A (62%) than definition B (80%), but specificity
was similar (89% vs. 87%). Comparing definition C
(HbA1c ≥6.5% or medication use) with definition D
(HbA1c ≥7.0% or medication use), we found the sensitivi-
ties to be 59% and 64%, respectively, and the specificities
were 87% and 85%, respectively. Both the sensitivities and
specificities with HbA1c definitions were lower than when
fasting glucose definitions were used. Definition E (fasting
glucose ≥126 mg/dL or HbA1c ≥6.5% or medication use)
had the lowest sensitivity (56%), the highest specificity
(91%), and the highest positive predictive value (55%) of
the 5 incident reference diabetes definitions.
Table 3 shows the reliability of self-reported diabetes
defined by the question: “Has a doctor ever said you have
diabetes (sugar in the blood)?” The percent positive
agreement (pairwise agreement between visit 4 and each
follow-up telephone call) was similar among those who
participated in all annual follow-up telephone calls (range:
92.7%–95.4%) and those who participated in at least 1
annual follow-up telephone call (range: 93.6%–95.9%).
This suggests that the participants who had complete
follow-up did not lead to an overestimation of reliability.
Overall, 237 (78.5%) of the 302 participants with diabetes
at visit 4 who took part in all annual follow-up telephone
calls reported diabetes during every annual follow-up tele-
phone call (i.e., high reliability). Of the remaining 65, 46
(70.8%) failed to report diabetes on only 1 of the 9 annual
follow-up phone calls. In our analyses of predictors of high
reliability, participants with coronary heart disease were more
likely to report with high reliability compared with persons
without heart disease (odds ratio = 6.02, 95% confidence
interval: 1.16, 31.30). No other factors examinedwere signifi-
cant predictors of high reliability (all values for P > 0.05).
DISCUSSION
Both prevalent self-reported diabetes and incident self-
reported diabetes were 84%–97% specific and 55%–80%
sensitive when multiple reference definitions were used.
Self-reported diabetes performed well for identifying diabe-
tes defined by fasting glucose, HbA1c, and/or medication
use. The reliability of self-reported diabetes was >92% at
all time points.
There are a number of studies that have shown high rates
of confirmation of self-reported diabetes diagnosis based
on information on medication, data from medical records,
and other sources (4–7). By contrast, there have been few
studies comparing self-reported diabetes with fasting
glucose and HbA1c (14, 15). Our results are consistent
with those of 2 prior studies reporting specificity and sensi-
tivity for prevalent self-reported diabetes compared with
fasting glucose ≥126 mg/dL or medication use (14, 15).
Another study (16) validated prevalent self-reported diabe-
tes status by using HbA1c ≥7.0% and medication data,
Table 3. Prospective Reliability of the “Has a Doctor Ever Said You Have Diabetes (Sugar in the Blood)?” Question Among Participants Who
Answered “Yes” to This Question at Visit 4 (1996–1998), the Atherosclerosis Risk in Communities Study
Participated in All Annual Follow-up Telephone Calls After Visit
4 and Prior to the Carotid MRI Visit (n = 302)
Participated in at Least 1 Annual Follow-up Telephone Call
After Visit 4 and Prior to the Carotid MRI Visit (n = 1,325)




















281 302 93.0 89.6, 95.6 426 455 93.6 91.0, 95.7
2 years after
visit 4
288 302 95.4 92.3, 97.4 787 832 94.6 92.8, 96.0
3 years after
visit 4
288 302 95.4 92.3, 97.4 1,178 1,238 95.2 93.8, 96.3
4 years after
visit 4
283 302 93.7 90.3, 96.2 1,139 1,195 95.3 94.0, 96.4
5 years after
visit 4
287 302 95.0 91.9, 97.2 1,099 1,151 95.5 94.1, 96.6
6 years after
visit 4
282 302 93.4 90.0, 95.9 1,044 1,105 94.5 93.0, 95.8
7 years after
visit 4
280 302 92.7 89.2, 95.4 1,001 1,065 94.0 92.4, 95.3
8 years after
visit 4
287 302 95.0 91.9, 97.2 967 1,009 95.9 94.4, 97.0
9 years after
visit 4
284 302 94.0 90.7, 96.4 911 951 95.8 94.3, 97.0
Abbreviations: CI, confidence interval; MRI, magnetic resonance imaging.
a Pairwise agreements between visit 4 and each follow-up telephone call.
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reporting results similar to those in the present study. Al-
though we were unable to compare prevalent self-reported
diabetes with HbA1c values at visit 4 (HbA1c measure-
ments were not available at this visit), the 98% specificity
and the 85% sensitivity reported in this study are consistent
with our comparison of incident diabetes with HbA1c
≥7.0% at the carotid MRI visit (16). Most prior studies
have not used HbA1c nor assessed multiple reference defi-
nitions using different cutpoints of diabetes biomarkers.
The positive predictive values for self-reported diabetes
were relatively low but ranged widely (14%–73%, depend-
ing on the reference definition). The difference in positive
predictive values across our definitions is largely explained
by differences in diabetes prevalence (e.g., prevalence
ranged from 4.0% (59/1,480) using definition D to 17.3%
(256/1,480) using definition E). The moderate sensitivities
for self-reported diabetes (<70% for prevalent and <80%
for incident self-reported diabetes) could represent partici-
pants who have not yet been diagnosed with diabetes by
their physician. The impact of misclassifying these individ-
uals as noncases depends on the study. A recent ARIC
Study analysis compared the relation between traditional di-
abetes risk factors with 3 different diabetes case definitions.
Magnitudes of association were lower for self-reported dia-
betes compared with definitions that also incorporated
fasting glucose, but risk factors remained significantly asso-
ciated with diabetes defined by self-report alone (17).
Certain limitations should be considered when interpret-
ing the results of this study. Participants may not have
brought all medications to the study visit, which could have
resulted in an underestimation of the validity of self-reported
diabetes. Additionally, test results conducted during the
study are reported to the participants, and often to their
physician, which could reduce the number of undiagnosed
cases and overestimate estimates of sensitivity compared
with the general population. HbA1c was not measured at
visit 4; therefore, we were unable to validate prevalent self-
reported diabetes against HbA1c. Our study also has a
number of strengths. We were able to validate self-reported
diabetes compared with multiple reference standards on the
basis of levels of fasting glucose and HbA1c, as well as
medication use. The annual follow-up telephone calls
allowed us to also validate incident self-reported diabetes
cases and to assess the reliability of the telephone question.
In summary, self-reported diabetes is 84%–97% specific
and 55%–80% sensitive as compared with multiple reference
definitions in this community-based population. Self-reported
diabetes is >92% reliable over time. Our results contribute
estimates of the error associated with the use of self-reported
diabetes versus diabetes defined by biomarkers and medica-
tion use. The acceptability of defining diabetes by self-report
will depend on the goals of the specific study.
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